Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients
Journal
Clinical Lung Cancer
Journal Volume
19
Journal Issue
3
Pages
e361-e372
Date Issued
2018
Author(s)
Wu T.-H.
Hsiue E.H.-C.
SDGs
Publisher
Elsevier Inc.
Type
journal article